Browsing Over 138 Presentations
Sort By
Educational session
New treatment in the current ovarian cancer beyond ADCs
Session Name
Speakers
- Nicoletta Colombo (Milan, Italy)
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Educational session
Do we still need radical surgery in the PARP inhibitor era?
Session Name
Speakers
- Giovanni Scambia (Rome, Italy)
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Educational session
PARP inhibitors: Mechanism of resistance and how to overcome
Session Name
Speakers
- Iain McNeish (London, United Kingdom)
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Educational session
How to select the best first line maintenance treatment? Is molecular profiling the only criteria to choose?
Session Name
Speakers
- Isabelle L. Ray-Coquard (Lyon, CEDEX, France)
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Educational session
Introduction
Session Name
Speakers
- Susana Banerjee (London, United Kingdom)
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
5 Minutes
Educational session
Q&A
Session Name
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Special Symposium
Is there a biological rationale to support decremental impact on overall survival?
Speakers
- Antonio Jose Gonzalez Martin (Madrid, Spain)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium
Why are we having this Symposium? Recent regulatory actions by FDA/EMEA regarding late-stage approval for PARPi in recurrent ovarian cancer
Speakers
- Robert L. Coleman (The Woodlands, TX, United States of America)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium
What is the impact of overall survival results of PARP inhibitor trials?
Speakers
- Susana Banerjee (London, United Kingdom)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium
Is there clinical evidence to support the link between PARPi use and a negative impact on OS?
Speakers
- Jonathan A. Ledermann (London, London, United Kingdom)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Special Symposium
Q&A
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
20 Minutes
Proffered Paper session
Q&A and discussion
Session Name
Date
Thu, 23.02.2023
Time
11:45 - 12:45
Room
Auditorium 113
Duration
8 Minutes